Marksans Pharma Ltd
NSE:MARKSANS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marksans Pharma Ltd
NSE:MARKSANS
|
IN |
|
Greenlane Holdings Inc
NASDAQ:GNLN
|
US |
|
S
|
Saipem SpA
F:SPE
|
IT |
|
InZinc Mining Ltd
F:32L
|
CA |
|
E
|
Euwax AG
F:EUX
|
DE |
|
Viel et Compagnie SA
PAR:VIL
|
FR |
|
Frontier Springs Ltd
NSE:FRONTSP
|
IN |
|
Owens Corning
NYSE:OC
|
US |
|
Global Brokerage Inc
OTC:GLBR
|
US |
|
O
|
Olin Corp
XMUN:OLN
|
US |
|
ARMOUR Residential REIT Inc
F:2AR
|
US |
|
T
|
Teva Pharmaceutical Industries Ltd
SWB:TEV
|
IL |
|
Viel et Compagnie SA
F:VIC
|
FR |
|
Erie Indemnity Co
F:EI2
|
US |
|
O
|
Oculus Inc
OTC:OVTZ
|
CA |
|
A
|
Ascopiave SpA
DUS:AVA
|
IT |
|
A
|
Alpha Services and Holdings SA
ATHEX:ALPHA
|
GR |
|
Suncorp Group Ltd
ASX:SUN
|
AU |
|
Origin Energy Ltd
ASX:ORG
|
AU |
|
Graphite One Inc
F:2JCA
|
CA |
|
Thungela Resources Ltd
F:6UP
|
ZA |
|
S
|
Star Fashion Culture Holdings Ltd
NASDAQ:STFS
|
CN |
|
K
|
Kopin Corp
XMUN:KOC
|
US |
|
Bitterroot Resources Ltd
XTSX:BTT
|
CA |
Intrinsic Value
Is MARKSANS undervalued or overvalued?
See the intrinsic value estimate for Marksans Pharma Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
MARKSANS looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with MARKSANS’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Marksans Pharma Does
Marksans Pharma makes generic medicines and over-the-counter healthcare products. It develops, manufactures, and sells tablets, capsules, and other finished dosage forms for pain relief, cough and cold, digestive health, allergies, and similar everyday treatments. The company works mainly as a manufacturer of branded and unbranded generics rather than as a drug discoverer, so its business is tied to producing approved medicines that match existing active ingredients.
- Headquarters
- India IN
- Employees
- 1 840
- IPO date
- Apr 3, 2002
Marksans Pharma has a narrow economic moat
Marksans Pharma Ltd has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
Marksans Pharma Ltd
Earnings Waterfall
Marksans Pharma Ltd
The intrinsic value for Marksans Pharma Ltd (MARKSANS) under the Base Case is hidden INR.
Compared with the current market price of 289.1 INR, the stock appears hidden.